Drug class
Nucleoside Metabolic Inhibitor
Mechanism of action
Nucleic Acid Synthesis Inhibitors [MoA]
General use cases
- newly diagnosed acute myeloid leukemia (AML) in adults 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
